Hyperscale Data director granted 250K stock options
Hyperscale Data, Inc. director Mordechai Rosenberg received a grant of stock options covering 250,000 shares of Class A common stock at an exercise price of $0.72 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Hyperscale Data, Inc. director Mordechai Rosenberg received a grant of stock options covering 250,000 shares of Class A common stock at an exercise price of $0.72 per share. These options expire on July 30, 2035 and represent compensation, not an open‑market purchase.
According to the vesting terms, 50% of the options vested and became exercisable on May 6, 2026, after stockholder approval and NYSE American approval of the grants. The remaining 50% vest in equal monthly installments over 24 months beginning June 1, 2026. Following this grant, Rosenberg holds 250,000 stock options directly.
Insider Trade Summary
Grant/Award: 250,000 shares
Grant/Award
1 txn
Insider
Rosenberg Mordechai
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (Right to Buy) | 250,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Options (Right to Buy) — 250,000 contracts (Direct)
Footnotes (1)
- F1. On July 31, 2025, the Board of Directors of the Issuer granted stock options to Mr. Rosenberg to purchase 250,000 shares of the Issuer's class A common stock. Fifty percent (50%) of these options vested and became exercisable on the date that receipt of approval of the option grants by the Issuer's stockholders and the NYSE American. Stockholder approval was obtained on April 10, 2026 and approval from the NYSE American was obtained on May 6, 2026, so May 6, 2026 was the date that these options vested and became exercisable. The remaining 50% vest in equal monthly increments over 24 months beginning June 1, 2026. The stock options were issued outside of any Issuer stock incentive plan.
Key Figures
Option grant size: 250,000 options
Exercise price: $0.72 per share
Expiration date: July 30, 2035
+3 more
6 metrics
Option grant size
250,000 options
Stock options to buy Class A common shares
Exercise price
$0.72 per share
Strike price for granted stock options
Expiration date
July 30, 2035
Option expiration for the 250,000-share grant
Immediate vesting portion
50% of options
Vested on May 6, 2026 after approvals
Remaining vesting period
24 months
Equal monthly vesting from June 1, 2026
Options held after grant
250,000 options
Total derivative holdings following transaction
Key Terms
Stock Options (Right to Buy), Class A Common Stock, vested and became exercisable, NYSE American, +2 more
6 terms
Stock Options (Right to Buy) financial
"security_title: "Stock Options (Right to Buy)""
Class A Common Stock financial
"underlying_security_title: "Class A Common Stock""
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
vested and became exercisable financial
"these options vested and became exercisable on the date that receipt of approval"
NYSE American financial
"approval of the option grants by the Issuer's stockholders and the NYSE American"
NYSE American is a stock exchange where companies can list their shares to be bought and sold by investors. It functions like a marketplace, helping businesses raise money and providing investors with opportunities to buy ownership in these companies. Its role is important because it facilitates the trading of smaller or emerging companies, offering investors access to a broader range of investment options.
stockholder approval financial
"Stockholder approval was obtained on April 10, 2026"
Stockholder approval is formal consent given by a company’s shareholders, usually through a vote at a meeting or by proxy, for major actions such as mergers, asset sales, changes to corporate structure, or amendments to governance rules. Investors pay attention because the vote can enable or block steps that materially change a company’s direction, ownership or value—like neighbors voting to allow a major renovation that would alter a building’s use and worth.
stock incentive plan financial
"The stock options were issued outside of any Issuer stock incentive plan."
A stock incentive plan is a company program that gives employees or directors pieces of ownership or the right to buy shares over time, similar to receiving a bonus paid in company stock instead of cash. Investors pay attention because these plans align staff incentives with long‑term company performance but can also dilute existing shareholders and affect reported profits when grants are expensed, so they influence both ownership percentages and financial results.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Hyperscale Data (GPUS) disclose about Mordechai Rosenberg’s Form 4 transaction?
Hyperscale Data reported that director Mordechai Rosenberg received a grant of stock options for 250,000 shares of Class A common stock at a $0.72 exercise price. The grant is compensation, not an open-market trade, and is documented as an acquisition on Form 4.
How many Hyperscale Data (GPUS) stock options were granted to Mordechai Rosenberg?
Mordechai Rosenberg was granted stock options covering 250,000 shares of Hyperscale Data’s Class A common stock. These options give him the right to buy shares at a fixed $0.72 exercise price, subject to the vesting schedule and expiration terms disclosed in the filing.
What is the exercise price and expiration date of Rosenberg’s Hyperscale Data (GPUS) options?
The granted options have an exercise price of $0.72 per share and expire on July 30, 2035. This means Rosenberg can choose to buy shares at $0.72 any time after they vest and before the July 2035 expiration, assuming he remains eligible under the grant terms.
How do the Hyperscale Data (GPUS) options granted to Rosenberg vest?
Half of the options vested on May 6, 2026, after stockholders and NYSE American approved the grants. The remaining 50% vest in equal monthly installments over 24 months starting June 1, 2026, creating a two-year vesting tail tied to continued service conditions.
Were Rosenberg’s Hyperscale Data (GPUS) options issued under a stock incentive plan?
The options were issued outside any Hyperscale Data stock incentive plan, according to the footnote. This means the grant did not come from an existing equity plan pool, but it still functions as equity-based compensation with the specified vesting and approval conditions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates